Amexdrug Corporation (AXRX) has an overall financial health rating of B with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2025-07-30.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-07-30 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-06-06 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-02-21 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
